After more than a decade studying a rare eye cancer that produces some of the hardest-to-fight tumors, researchers from ...

A type of therapy that involves “liberating” T cells from a suppressive tumor environment showed promise in the treatment of ...

There are two types of damaging rays: UVA and UVB. ‘UVA rays pass through the front of the eye to the lens, and there’s a ...

The Melanoma Research Alliance (MRA), the world's leading non-profit funder of melanoma research, announced its $12.6 million ...

New research from the University of Pittsburgh explains why metastatic uveal melanoma is resistant to conventional immunotherapies and how adoptive therapy, which involves growing a patient's T cells ...

Defects in RNA processing can promote cancer -- but the mutated proteins responsible can be hard to target. Fred Hutch Cancer ...

New research explains why metastatic uveal melanoma is resistant to conventional immunotherapies and how adoptive therapy, which involves growing a patient's T cells outside the body before reinfusing ...

IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of ...

A gene expression score may be able to predict outcomes of adoptive cell therapy and prevent unnecessary surgeries in patients with uveal melanoma, researchers say.

Fintel reports that on April 29, 2024, Leerink Partners initiated coverage of Immunocore Holdings plc - Depositary Receipt () ...

German biotech Immatics has two major data readouts due 2H24, and a pivotal study initiation in melanoma - the risk reward is ...

Immunocore announces upcoming presentation and posters at ASCO 2024Phase 1 expansion data in immune checkpoints pre-treated cutaneous melanoma ...